Ocuphire Pharma Cash on Hand 2010-2024 | IRD

Ocuphire Pharma cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Ocuphire Pharma Annual Cash on Hand
(Millions of US $)
2023 $51
2022 $43
2021 $25
2020 $16
2019 $2
2018 $15
2017 $27
2016 $20
2015 $23
2014 $33
2013 $19
2012 $14
2011 $12
2010 $15
2009 $7
Ocuphire Pharma Quarterly Cash on Hand
(Millions of US $)
2024-06-30 $41
2024-03-31 $47
2023-12-31 $51
2023-09-30 $42
2023-06-30 $40
2023-03-31 $39
2022-12-31 $43
2022-09-30 $14
2022-06-30 $17
2022-03-31 $19
2021-12-31 $25
2021-09-30 $23
2021-06-30 $24
2021-03-31 $11
2020-12-31 $16
2020-09-30 $8
2020-06-30 $9
2020-03-31 $11
2019-12-31 $2
2019-09-30 $14
2019-06-30 $16
2019-03-31 $18
2018-12-31 $15
2018-09-30 $13
2018-06-30 $17
2018-03-31 $21
2017-12-31 $27
2017-09-30 $23
2017-06-30 $27
2017-03-31 $19
2016-12-31 $20
2016-09-30 $22
2016-06-30 $19
2016-03-31 $24
2015-12-31 $23
2015-09-30 $21
2015-06-30 $26
2015-03-31 $29
2014-12-31 $33
2014-09-30 $36
2014-06-30 $38
2014-03-31 $40
2013-12-31 $19
2013-09-30 $15
2013-06-30 $10
2013-03-31 $12
2012-12-31 $14
2012-09-30 $7
2012-06-30 $9
2012-03-31 $10
2011-12-31 $12
2011-09-30 $15
2011-06-30 $18
2011-03-31 $23
2010-12-31 $15
2010-09-30 $16
2010-06-30 $18
2010-03-31 $8
2009-12-31 $7
2009-09-30 $4
2009-06-30 $4
2009-03-31 $3
Sector Industry Market Cap Revenue
$0.000B $0.000B
Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.
Stock Name Country Market Cap PE Ratio
Fanhua (AIFU) China $0.086B 2.07
Top KingWin (WAI) China $0.008B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.004B 0.00